User blogs

Inflammatory Bowel Disease Drugs Market AnalysisThe global Inflammatory Bowel Disease (IBD) Drugs Market, valued at USD 21.15 billion in 2023, is expected to reach USD 27.65 billion by 2031, growing at a compound annual growth rate (CAGR) of 3.47% during the forecast period from 2024 to 2031.Inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, is a chronic condition characterized by inflammation of the gastrointestinal tract. The market growth is driven by increasing prevalence of IBD, advancements in bi... more